European Patent Office

T 1938/09 (TRANSDERMAL DELIVERY OF BUPRENORPHINE / EURO-CELTIQUE) du 09.03.2015

Identifiant européen de la jurisprudence
ECLI:EP:BA:2015:T193809.20150309
Date de la décision
9 mars 2015
Numéro de l'affaire
T 1938/09
Requête en révision de
-
Numéro de la demande
98906678.2
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents des chambres de recours (C)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Résumés pour cette décision
-
Titre de la demande
SUSTAINED ANALGESIA ACHIEVED WITH TRANSDERMAL DELIVERY OF BUPRENORPHINE
Nom du demandeur
EURO-CELTIQUE S.A.
Nom de l'opposant
Hexal AG
Acino AG
Chambre
3.3.02
Sommaire
-
Dispositions juridiques pertinentes
Basic proposal for the revision of the EPC MR/2/00European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(3)European Patent Convention Art 114(2)European Patent Convention Art 116(4)European Patent Convention Art 123(2)European Patent Convention Art 24European Patent Convention Art 54(2)Rules of procedure of the Boards of Appeal Art 13Rules of procedure of the Boards of Appeal Art 15(2)Rules of procedure of the Boards of Appeal Art 3(2)
Mots-clés
Admissibility of objection of partiality (yes) - No delay and sufficient substantiation
Admissibility of auxiliary requests (yes) - Bona fide attemps to remedy newly raised deficiencies
Admissibility of auxiliary requests (no) - Not clearly allowable and raising complex problems at late stage
Postponement of oral proceedings because of pending petition for review of a decision rejecting an objection based on suspected partiality (no) - No suspensive effect
Referral of questions to the Enlarged Board of Appeal (no)
Amendments - extension beyond the content of the application as filed (yes)
Claims - clarity after amendment (no)
Exergue
-
Affaires citantes
R 0016/22

Order

For these reasons it is decided that:

The appeal is dismissed.